Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (hpa)-axis function
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
The use of intra-articular (IA) glucocorticoids for reducing pain and inflammation in patients with osteoarthritis, rheumatoid arthritis, and other inflammatory arthropathies is widespread among primary care physicians, specialists, and non-specialists in the United States. Injectable glucocorticoids have anti-inflammatory and analgesic properties which can be effective in improving clinical parameters such as pain, range of motion, and quality of life. After injection into the IA space, glucocorticoids may be systemically absorbed; the degree of absorption can depend on the size of the joint injected, the injectable glucocorticoid preparation used, the dosage, and the frequency of the injection. The adverse effects of intra-articular glucocorticoid injections (IAGC) can often be overlooked by both the patient and physicians who administer them, in particular the potential deleterious effect on the hypothalamic-pituitary-adrenal (HPA)-axis which can result in adrenal suppression and/or iatrogenic Cushing syndrome. In this paper we provide an overview on the often under-recognized effects of IAGC on HPA-axis function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other cases of interaction leading to iatrogenic Cushing’s syndrome and tertiary hypoadrenalism have been described in HIV patients between ritonavir and inhaled GCs [76], but also, with the same mechanisms, in patients treated with intra-articular [42] or topical GCs who were taking protease inhibitors, itraconazole, macrolides, and diltiazem [45].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [42]
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 1×
“Cushing syndrome is typically demonstrated by elevations in serum or urine cortisol, sequential midnight salivary cortisol as well as dexamethasone suppression testing [65, 66].”
THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
(1972) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-197254060-00035 · Cited by 1,647
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886 · cited 1×
“IAGC are absorbed at a slower rate when injected into a joint in contrast to a comparable oral dose, and are typically retained in the IA cavity for 2–3 weeks after a single injection [23].”
Intraarticular corticosteroid for treatment of osteoarthritis of the knee
Bellamy, N., Campbell, J., Welch, V., Gee, T. L., Bourne, R., & Wells, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005328.pub2 · Cited by 762
Kudielka, B. M., & Kirschbaum, C. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00008-2 · Cited by 456
Cyclooxygenase isozymes and their gene structures and expression
Tanabe, T., & Tohnai, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00024-2 · Cited by 422 · cited 1×
“They modulate the immune and inflammatory cascade, in particular suppression of pro-inflammatory cytokines including interleukin 1b and IFNa, in addition to mediation of inflammatory enzymes including arachidonic acid and its metabolites [19, 20].”
Hollander, J. L. (1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.03670340019005 · Cited by 421
Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function.
LAUDAT, M. H., CERDAS, S., FOURNIER, C., GUIBAN, D., GUILHAUME, B., & LUTON, J. P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-343 · Cited by 393
Corticosteroid injections for osteoarthritis of the knee: Meta-analysis
Arroll, B., & Goodyear-Smith, F. (2004) · BMJ · doi:10.1136/bmj.38039.573970.7c · Cited by 348
Ringold, S., Weiss, P. F., Beukelman, T., DeWitt, E. M., Ilowite, N. T., Kimura, Y., Laxer, R. M., Lovell, D. J., Nigrovic, P. A., Robinson, A. B., et al. (2013) · Arthritis Care & Research · doi:10.1002/acr.22087 · Cited by 306
Cushing’s Syndrome: important issues in diagnosis and management
Findling, J. W., & Raff, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0997 · Cited by 294 · cited 1×
“There is an increased risk of developing diabetes, hypertension, and a predisposition to opportunistic infections [64].”
Derendorf, H., Möllmann, H., Grüner, A., Haack, D., & Gyselby, G. (1986) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1986.45 · Cited by 279
Systemic effects of intra-articular corticosteroids
Habib, G. S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1135-x · Cited by 273 · cited 3×
“betamethasone, TH usually takes 2–4 weeks, and TA is normally beyond 28 days [7, 9, 49].”
Musculoskeletal injections: a review of the evidence.
Stephens, M. B., Beutler, A. I., & O’Connor, F. G. (2008) · PubMed · Cited by 225
Injectable Corticosteroids in Modern Practice
Cole, B. J., & Schumacher, R. H. (2005) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-200501000-00006 · Cited by 223
Intra-Articular Corticosteroids: Guide to Selection and Indications for Use
Caldwell, J. R. (1996) · Drugs · doi:10.2165/00003495-199652040-00004 · Cited by 208
Clinical Pharmacokinetics of Prednisone and Prednisolone
Frey, B. M., & Frey, F. J. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019020-00003 · Cited by 197
Measurement of salivary cortisol in 2012 – laboratory techniques and clinical indications
Inder, W. J., Dimeski, G., & Russell, A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04508.x · Cited by 195 · cited 1×
“Cortisol in saliva is stable at room temperature for at least a week and can be mailed to the laboratory for analysis [58, 59].”
Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186
Evidence-Based Knee Injections for the Management of Arthritis
Cheng, O. T., Souzdalnitski, D., Vrooman, B., & Cheng, J. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01394.x · Cited by 169 · cited 2×
“treatment of rheumatoid arthritis, osteoarthritis, crystalline arthropathies, and other inflammatory arthropathies when conventional therapy has not controlled pain [4, 5].”
Intra-articular therapy in osteoarthritis
Uthman, I., Raynauld, J.-P., & Haraoui, B. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.934.449 · Cited by 156
Scott, D. L., Shipley, M., Dawson, A., Edwards, S., Symmons, D. P., & Woolf, A. D. (1998) · Rheumatology · doi:10.1093/rheumatology/37.5.546 · Cited by 155 · cited 1×
“injections are currently lacking [10–14].”
Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how?
Creamer, P. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.11.634 · Cited by 145 · cited 1×
“They modulate the immune and inflammatory cascade, in particular suppression of pro-inflammatory cytokines including interleukin 1b and IFNa, in addition to mediation of inflammatory enzymes including arachidonic acid and its metabolites [19, 20].”
Baid, S. K., Sinaii, N., Wade, M., Rubino, D., & Nieman, L. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2861 · Cited by 144 · cited 1×
“The use of liquid chromatography-tandem mass spectrometry (LC–MS/MS) to measure salivary cortisol, avoids the problem of cross reactivity from synthetic steroids, or other interfering medications [60, 61].”
Epidural triamcinolone suppresses the pituitary-adrenal axis in human subjects
Kay, J., Findling, J. W., & Raff, H. (1994) · Anesthesia & Analgesia · doi:10.1213/00000539-199409000-00017 · Cited by 135 · cited 1×
“However, it is more common after repeated injections and associated with HPA-axis suppression or in patients who are taking other medications that can alter the pharmacodynamics of glucocorticoids and potentiate their effects [24, 32, 36, 39, 41, 42, 67–75].”
Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate.
Armstrong, R. D., English, J., Gibson, T., Chakraborty, J., & Marks, V. (1981) · Annals of the Rheumatic Diseases · doi:10.1136/ard.40.6.571 · Cited by 129
Bird, H. A., Ring, E. F. J., & BACON, P. A. (1979) · Annals of the Rheumatic Diseases · doi:10.1136/ard.38.1.36 · Cited by 128
Salivary Cortisol for Assessment of Hypothalamic-Pituitary-Adrenal Axis Function
Törnhage, C.-J. (2009) · Neuroimmunomodulation · doi:10.1159/000216186 · Cited by 118 · cited 1×
“Morning salivary cortisol is a potentially useful indicator of adrenal suppression and can assess changes in HPA-axis function [55, 56].”
Intra-articular corticosteroid injections in juvenile idiopathic arthritis
Cleary, A. G. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.3.192 · Cited by 113 · cited 1×
“studies examining the effects of glucocorticoid joint injections on HPA-axis function have been in adult patients with osteoarthritis and rheumatoid arthritis, in addition these studies have particularly focused on the knee joint which has a large synovial resorption area, therefore, the influence of IAGC and their su…”
Glucocorticoid-induced diabetes and adrenal suppression: How to detect and manage them
Lansang, M. C., & Hustak, L. K. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10180 · Cited by 105
Self-citationAdvantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders
Restituto, P., Galofré, J. C., Gil, M. J., Mugueta, C., Santos, S. M. E., Monreal, J. I., & Varo, N. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.01.015 · Cited by 102 · cited 1×
“Although single salivary cortisol measurements do not confirm adrenal insufficiency without the use of the corticotropin stimulation testing they are nonetheless useful diagnostic predictors of HPA-axis function [62].”
Intra-articular injections for osteoarthritis of the knee.
Neustadt, D. H. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.10.897 · Cited by 100 · cited 1×
“treatment of rheumatoid arthritis, osteoarthritis, crystalline arthropathies, and other inflammatory arthropathies when conventional therapy has not controlled pain [4, 5].”
Cushing's syndrome from epidural methylprednisolone
Tuel, S. M., Meythaler, J. M., & Cross, L. L. (1990) · Pain · doi:10.1016/0304-3959(90)91054-m · Cited by 89
Intra-articular corticosteroids: an updated overview.
Rozental, T. D., & Sculco, T. P. (2000) · PubMed · Cited by 87
Reduction of cortisol levels after single intra-articular and intramuscular steroid injection
Lazarevic, M. B., Skosey, J. L., Djordjevic-Denic, G., Swedler, W. I., Zgradic, I., & Myones, B. L. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80183-1 · Cited by 86
Mader, R., Lavi, I., & Luboshitzky, R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20884 · Cited by 83
Kumar, S., Singh, R. J., Reed, A. M., & Lteif, A. N. (2004) · Pediatrics · doi:10.1542/peds.113.6.1820 · Cited by 79
Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy
Bartoszek, M., Brenner, A. M., & Szefler, S. J. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.173 · Cited by 74
Marsland, D., Mumith, A., & Barlow, I. W. (2013) · The Knee · doi:10.1016/j.knee.2013.07.003 · Cited by 73
Intra-articular corticosteroid injections: A critical literature review with up-to-date findings
Pekarek, B., Osher, L. S., Buck, S., & Bowen, M. (2011) · The Foot · doi:10.1016/j.foot.2010.12.001 · Cited by 70 · cited 3×
“betamethasone, TH usually takes 2–4 weeks, and TA is normally beyond 28 days [7, 9, 49].”
Side effects of corticosteroid injections: What's new?
Berthelot, J., Goff, B. L., & Maugars, Y. (2013) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.12.001 · Cited by 66
Magnotti, M., & Shimshi, M. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.233 · Cited by 62
Perogamvros, I., Owen, L. J., Keevil, B. G., Brabant, G., & Trainer, P. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03582.x · Cited by 61
High Risk of Adrenal Insufficiency after a Single Articular Steroid Injection in Athletes
DUCLOS, M., GUINOT, M., COLSY, M., MERLE, F., BAUDOT, C., CORCUFF, J. B., & LEBOUC, Y. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31805468d6 · Cited by 55
Lavelle, W. F., Lavelle, E. D., & Lavelle, L. A. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.12.002 · Cited by 52
Habib, G., Jabbour, A., Artul, S., & Hakim, G. (2014) · Clinical Rheumatology · doi:10.1007/s10067-013-2374-4 · Cited by 52 · cited 1×
“Interestingly in this study, one patient had adrenal suppression which recurred after 2 weeks suggesting that the systemic absorption of corticosteroids from the knee joint can be variable over time [51].”
Andrews, M. H., Wood, S., Windle, R., Lightman, S., & Ingram, C. (2011) · Endocrinology · doi:10.1210/en.2011-1434 · Cited by 50
Use of Injections for Osteoarthritis in Joints and Sports Activity
Snibbe, J. C., & Gambardella, R. A. (2005) · Clinics in Sports Medicine · doi:10.1016/j.csm.2004.08.001 · Cited by 49
Weitoft, T., & Rönnblom, L. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041525 · Cited by 48 · cited 3×
“Serum cortisol has shown a significant but reversible decrease with the earliest change seen within 4 h, and maximum response seen between days 1–2 but in some instances up to 4 days [31, 32, 36, 38, 43].”
Huppertz, H., & Pfüller, H. (1997) · PubMed · Cited by 45
Diagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injections
Lansang, M. C., Farmer, T., & Kennedy, L. (2009) · Endocrine Practice · doi:10.4158/ep.15.3.225 · Cited by 45 · cited 2×
“However, screening urine as far along as nine months after the most recent steroid injection, has detected the presence of synthetic glucocorticoids in some instances, and demonstrates the potential for a long systemic duration of action even after a single depot injection [24].”
Self-citationO’Sullivan, M., RUMFELD, W. R., Jones, M. K., & Williams, B. D. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.8.561 · Cited by 42 · cited 2×
“However, it is more common after repeated injections and associated with HPA-axis suppression or in patients who are taking other medications that can alter the pharmacodynamics of glucocorticoids and potentiate their effects [24, 32, 36, 39, 41, 42, 67–75].”
Hypothalamic–pituitary–adrenal axis regulation of inflammation in rheumatoid arthritis
Morand, E. F., & Leech, M. (2001) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2001.01028.x · Cited by 41 · cited 1×
“in rheumatoid arthritis and that deficiencies in HPA-axis function can pre-dispose individuals to severity of disease and its onset [33, 34].”
Lavelle, W. F., Lavelle, E. D., & Lavelle, L. A. (2007) · Anesthesiology Clinics · doi:10.1016/j.anclin.2007.07.002 · Cited by 41
A consumer's guide to finding, evaluating, and reporting on measurement instruments
DeVellis, R. F. (1996) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199606)9:3<170::aid-anr1790090304>3.0.co;2-k · Cited by 38
Gondwe, J. S., Davidson, J. E., Deeley, S., Sills, J., & Cleary, A. G. (2005) · Rheumatology · doi:10.1093/rheumatology/kei154 · Cited by 33 · cited 2×
“demonstrated that 5 % developed a Cushingoid appearance after injection with the less soluble preparation TA, this was not seen in the children who received TH [69].”
Salivary Cortisol Concentration Changes After Epidural Steroid Injection
Moon, H. S. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/461 · Cited by 31
Schwarze‐Zander, C., Klingmüller, D., Klümper, J., Strassburg, C. P., & Rockstroh, J. (2013) · Infection · doi:10.1007/s15010-013-0506-z · Cited by 30
Jansen, T., & Roon, V. E. (2002) · PubMed · Cited by 29
Risk, benefits and complications of epidural steroid injections: a case report.
Snarr, J. (2007) · PubMed · Cited by 27
Diagnostic Value of Salivary Cortisol in Children with Abnormal Adrenal Cortex Functions
Cetinkaya, S., Ozon, A., & Yordam, N. (2007) · Hormone Research in Paediatrics · doi:10.1159/000100363 · Cited by 27
Weitoft, T., Larsson, A. O., & Rönnblom, L. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081315 · Cited by 27
The Influence of Uremia on Pharmacokinetics and Protein Binding of Prednisolone
Bergrem, H. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb03747.x · Cited by 25 · cited 1×
“The effect of systemic absorption of the injected steroid is also dependent on a number of other factors including vascularity of the synovium, chronic renal and liver disease, hypo- or hyperthyroidism as well as obesity, and the use of enzyme inducers, medications that can affect cytochrome p450 (CYP) enzyme inhibiti…”
Secondary Cushing’s Syndrome After A Single Epidural Injection Of A Corticosteroid
Horani, M. H., & Silverberg, A. B. (2005) · Endocrine Practice · doi:10.4158/ep.11.6.408 · Cited by 24
Habib, G., Artul, S., Chernin, M., Hakim, G., & Jabbour, A. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3182a67871 · Cited by 24
Maviki, M., Cowley, P., & Marmery, H. (2012) · Skeletal Radiology · doi:10.1007/s00256-012-1539-6 · Cited by 22
Habib, G., Khazin, F., Jabbour, A., Chernin, M., Badarny, S., Hakim, J., & Artul, S. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000048 · Cited by 21
Clinical and pharmacological aspects of accidental triamcinolone acetonide overdosage: a case study
Schweitzer, D. H. (2000) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(99)00085-6 · Cited by 20
Sudden loss of milk supply following high-dose triamcinolone (Kenacort) injection.
McGuire, E. (2012) · PubMed · Cited by 16
Hypothalamic-pituitary-adrenal axis suppression after repeated intra-articular steroid injections.
Reid, D. M., Eastmond, C. J., & Rennie, J. A. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.1.87 · Cited by 15
Leary, J., & Swislocki, A. (2013) · Case Reports in Endocrinology · doi:10.1155/2013/617042 · Cited by 14 · cited 1×
“However, it is more common after repeated injections and associated with HPA-axis suppression or in patients who are taking other medications that can alter the pharmacodynamics of glucocorticoids and potentiate their effects [24, 32, 36, 39, 41, 42, 67–75].”
[Intra-articular glucocorticoid injections in joint diseases].
Østergaard, M., & HALBERG, P. (1999) · PubMed · Cited by 12
von M�hlendahl, K. E., Weber, B., Müller-Hess, R., KORTH-SCHÜTZ, S., & Helge, H. (1978) · European Journal of Pediatrics · doi:10.1007/bf00496996 · Cited by 7
Kothakota, B., & Waseem, M. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2507-0_107 · Cited by 2
Straub, R. H., & Cutolo, M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<493::aid-anr95>3.0.co;2-u · cited 1×
“in rheumatoid arthritis and that deficiencies in HPA-axis function can pre-dispose individuals to severity of disease and its onset [33, 34].”
Research works printed but not linked: 1
- B.J. Bloom, L.C. Miller, L.B. Tucker, A.J. Alario, J.G. Schaller, Intra-articular corticosteroids in juvenile chronic arthritis. Arthritis 39, S46 (1997)
Cited by
Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181
“inhaled GCs [76], but also, with the same mechanisms, in patients treated with intra-articular [42] or topical GCs who were taking protease inhibitors, itraconazole, macrolides, and diltiazem [45].”
BackgroundMethodInfluentialSystemic Absorption and Side Effects of Locally Injected Glucocorticoids
Stout, A., Friedly, J., & Standaert, C. J. (2019) · PM&R · doi:10.1002/pmrj.12042 · Cited by 170
“In addition, the duration of HPA axis suppression after intra-articular glucocorticoid injection also has individual patient variability for which specific risk factors have not been identified.(18) Regarding dose effects, one study of 21 patients with methylprednisolone 40 or 80 mg injected into one or both knees fou…”
BackgroundMethodGlucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Systemic effects of epidural steroid injections for spinal stenosis
Friedly, J. L., Comstock, B. A., Heagerty, P. J., Bauer, Z., Rothman, M. S., Suri, P., Hansen, R. N., Avins, A. L., Nedeljković, S. S., Nerenz, D. R., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001158 · Cited by 102
Glucocorticoid signaling and osteoarthritis
Savvidou, O. D., Milonaki, M., Goumenos, S. D., Flevas, D. A., Papagelopoulos, P. J., & Moutsatsou, P. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.11.001 · Cited by 48
Metadata
- Authors
- Johnston, P. C., Lansang, M. C., Chatterjee, S., & Kennedy, L.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Johnston, Philip C.
- Venue
- Endocrine
- Published
- 2014-09-03
- Volume
- 48
- Issue
- 2
- Pages
- 410-416
- ISSN
- 0969-711X (ISSN-L)
- 1355-008X
- 1559-0100
- OpenAlex
- W1972453271
- Cited by
- 58
- References
- 76
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 3 · 2021: 11 · 2020: 4 · 2019: 7 · 2018: 6 · 2017: 1 · 2016: 4 · 2015: 1
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Endocrine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- intra-articular corticosteroid injection, hypothalamic-pituitary-adrenal axis, adrenal suppression, iatrogenic Cushing's syndrome, osteoarthritis, rheumatoid arthritis, inflammatory arthritis, glucocorticoid adverse effects
- MeSH terms
- Glucocorticoids, Humans, Hypothalamo-Hypophyseal System, Injections, Intra-Articular, Pituitary-Adrenal System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.